中國人民保險集團(01339.HK):羅熹獲委任為執行董事兼董事長
格隆匯 10 月 12日丨中國人民保險集團(01339.HK)發佈公告,經出席董事會會議的本公司董事表決,董事會審議通過了《關於提名羅熹先生為公司第三屆董事會執行董事候選人的議案》和《關於選舉羅熹先生為公司第三屆董事會董事長的議案》。
依公司董事會會議通過的決議,羅熹獲委任為公司第三屆董事會執行董事、董事長,羅熹擔任執行董事、董事長的任期自公司股東大會選舉其為執行董事並其董事任職資格獲得中國銀保監會核准之日起算,至公司第三屆董事會任期屆滿時止,任期屆滿可以重選連任。根據公司章程的規定,董事會戰略與投資委員會主任委員由董事長擔任。待中國銀保監會核准羅熹的董事任職資格後,羅熹將擔任董事會戰略與投資委員會主任委員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.